MCK MCK マケッソン

 MCKのチャート


 MCKの企業情報

symbol MCK
会社名 McKesson Corp (MCK マケッソン)
分野(sector)   
産業(industry)   
業種 小売_医薬品   医療関連(Health Care)
概要 事業概要 マケッソン(McKesson Corporation)はヘルスケア・サプライチェーン・マネジメント・ソリューション、小売薬局、コミュニティ腫瘍と専門医療、医療情報技術企業である。同社は医薬品製造業者、プロバイダー、薬局、政府その他の医療機関と提携することにより、医薬品、医療製品、医療サービスを提供する。同社はマケッソン販売ソリューションとマケッソン技術ソリューションの2つのセグメントを通じて事業を展開する。販売ソリューション事業はブランド医薬品およびジェネリック医薬品、その他のヘルスケア関連製品を国際的に流通させ、管理、技術、臨床サポートおよびビジネスソリューションを地域ベースの腫瘍学およびその他の専門分野に提供する。技術ソリューション事業はソフトウェアと分析、ネットワークソリューション、テクノロジー対応サービスを提供する。  マッケソンは米国の医薬品卸売業者。北米で処方薬、医薬品、手術用具・機器、ヘルスケア薬品の卸売りを行うほか、製薬会社向けに特殊医療品の物流サ―ビス、また薬局向けに経営コンサルティング、自動調剤システムなどを提供。病院向けには診療管理用ソフト「インタ―クォ―ル」のほか、患者情報、医療画像管理、財務管理など各種ソフトを提供。本社はサンフランシスコ。  McKesson Corp. engages in the provision of supply chain management solutions, retail pharmacy, community oncology and specialty care, and healthcare information technology. It operates through the following segments: U.S. Pharmaceutical and Specialty Solutions; European Pharmaceutical Solutions; Medical-Surgical Solutions and Other. The U.S. Pharmaceutical and Specialty Solutions segment distributes pharmaceutical and other healthcare-related products and also provides pharmaceutical solutions to pharmaceutical manufacturers in the United States. The European Pharmaceutical Solutions segment provides distribution and services to wholesale, institutional and retail customers and serves patients and consumers in 13 European countries. The Medical-Surgical Solutions segment focuses on medical-surgical supplies and provides logistics and other services to healthcare providers in the United States. The Other segment comprises on McKesson Canada, McKesson Prescription Technology Solutions and in a joint venture. The company was founded by John McKesson and Charles Olcott in 1833 and is headquartered in Irving, TX.
本社所在地 One Post Street San Francisco CA 94104 USA
代表者氏名 John Harvey Hammergren
代表者役職名 Chairman of the Board Chief Executive Officer
電話番号 +1 415-983-8300
設立年月日 34516
市場名 NYSE(ニューヨーク証券取引所)
ipoyear
従業員数 78000人
url www.mckesson.com
nasdaq_url
adr_tso
EBITDA EBITDA(百万ドル) 4228.00000
終値(lastsale)
時価総額(marketcap)
時価総額 時価総額(百万ドル) 22455.07000
売上高 売上高(百万ドル) 213518.00000
企業価値(EV) 企業価値(EV)(百万ドル) 30390.07000
当期純利益 当期純利益(百万ドル) -371.00000
決算概要 決算概要 BRIEF: For the nine months ended 31 December 2018 McKesson Corporation revenues increased 3% to $161.89B. Net income before extraordinary items increased from $384M to $818M. Revenues reflect U.S. Pharmaceutical and Specialty Solutions segment increase of 3% to $126.87B Medical-Surgical Solutions segment increase of 16% to $5.66B European Pharmaceutical Solutions segment increase of 2% to $20.49B.

 MCKのテクニカル分析


 MCKのニュース

   Global Medication Management System Market 2020 Indepth Study Including COVID 19 Update with of Top Key Players Profile: Allscripts, Healthcare Solutions., ARxIUM, BD, Cerner Corporation, GE Healthcare, McKesson Corporation  2020/10/09 20:09:43 OpenPR
Data Bridge Market Research has recently added a concise research on the Global Medication Management System Market to depict valuable insights related to significant market trends driving the industry. The report features analysis based on key opportunities and challenges confronted
   Radiology Information Systems (RIS) Market Undertake Strapping Growth By 2020 With Koninklijke Philips N.V., Siemens Healthineers AG, Bayer AG, Cerner Corporation, General Electric Company, McKESSON CORPORATION  2020/10/09 14:13:13 OpenPR
The radiology information systems (RIS) market is expected to reach US$ 1,693.50 million by 2027 from US$ 904.60 million in 2019; the market is estimated to grow at a CAGR of 8.3% during 2020–2027. The key players profiled in the Radiology
   Telemental Health Market (COVID - 19 Updates) 2020 A look At Current And Upcoming Growth, Leading Players are McKesson Corporation (US), Koninklijke Philips N.V. (Netherlands), Otsuka America Pharmaceutical Inc. (US), Cerner Corporation (US)  2020/10/08 17:10:01 OpenPR
This Telemental Health Market research report is a detailed synopsis on the study of industry and its impact on the market environment. By systematically understanding and keeping into thought customer requirement, one step or combination of many steps has been
   Healthcare Supply Chain Management Market to Show Incredible Growth by 2025 || McKesson Corporation, Tecsys Inc., Global Healthcare Exchange, LLC., Cardinal Health., Epicor Software Corporation, LLamasoft Inc  2020/10/08 17:08:08 OpenPR
Data Bridge Market Research has added an exhaustive research study of the Healthcare Supply Chain Management Market driver and intricately analyzing the business vertical. The research report has abilities to raise as the most significant market worldwide as it has
   E-prescribing solutions market Likely to Experience a Tremendous Growth in Near Future|| Allscripts Healthcare, LLC, athenahealth, Inc., Cerner Corporation, DrFirst, eClinicalWorks, McKesson Corporation  2020/10/07 20:53:29 OpenPR
E- Prescribing Solutions Market research report has been prepared with a nice combination of industry insight, smart solutions, practical solutions and newest technology to give better user experience. Under market segmentation chapter, research and analysis is done based on several
   Global Telemental Health Market 2020-2027 Major Players Hitting the Reset Button || AMD Global Telemedicine, Inc (US), Aerotel Medical Systems (1998) Ltd. (Israel), Medtronic (Ireland), F. Hoffmann-La Roche Ltd. (Switzerland), McKesson Corporation  2020/09/28 18:13:25 OpenPR
According to this Global Telemental Health Market report, the key market players are making moves like product launches, joint ventures, developments, mergers and acquisitions which has influence on the market and Industry as a whole and also affecting the sales,
   McKesson Ventures Grows Leadership Team with New Partner Promotions  2020/09/16 12:55:00 Business Wire
SAN FRANCISCO--(BUSINESS WIRE)--McKesson Ventures, the venture capital arm of McKesson Corporation, announces the expansion of its leadership team, promoting Jennifer Carter and Carrie Hurwitz Williams to partners of McKesson Ventures. The new partner roles exemplify McKesson Ventures’ growth since it was established in 2014. As partner, Carter and Williams will identify long-term strategic industry opportunities, invest in healthcare technology companies and build valuable partnerships with Mc
   Here Is Everything We Know About A COVID-19 Vaccine  2020/09/04 09:30:00 Zero Hedge
Here Is Everything We Know About A COVID-19 Vaccine Tyler Durden Fri, 09/04/2020 - 05:30 Under normal conditions, vaccines require as long as ten years of testing before they're approved by regulators, then it takes some more time for drug companies to produce and distribute the product to millions of patients around the world. Until very recently, the notion that the world could quickly develop and mass produce a vaccine for some new infectious disease within a matter of months seemed impossible. Of course, these aren't normal times. After unveiling the adenovirus-vector vaccine developed by the Gameleya Institute, Russian President Putin claimed that the vaccine was tested first on a small group of willing participants, including one of his own adult daughters. The implication was that traditional standards of medical ethics don't always apply during extreme situations. With vaccine news being the dominant story on Thursday , as investors around the world watched as the administration pushed the states to prepare to start distributing vaccine doses on an emergency basis come Nov. 1.
   CDC tells states to be ready for vaccines from Trump's 'Operation Warp Speed' on November 1 — two days before the election  2020/09/03 10:00:23 Business Insider
Summary List Placement The Trump administration has asked states to get ready to distribute a coronavirus vaccine by November 1, two days before the presidential election. The request was made in a letter, reported by multiple news outlets including The Wall Street Journal , New York Times , and Politico . In the letter, Centers for Disease Control and Prevention (CDC) chief Robert Redfield asks governors to cut any red tape that would prevent distribution centers from hitting the deadline. "CDC urgently requests your assistance in expediting applications for these distribution facilities, and, if necessary, asks that you consider waiving requirements that would prevent these facilities from becoming fully operational by Nov. 1, 2020," it said. Dallas-based company McKesson Corp and its subsidiaries have secured the government contract to distribute the vaccine, according to the Journal. President Donald Trump has sought to accelerate research and production of a vaccine via Operation Warp Speed, a government program which had an initial internal deadline of October, according to a slide deck seen by The New York Times .
   Anfang November anvisiert: USA bereiten Impfstoff-Verteilung vor  2020/09/03 07:16:26 KURIER Medienhaus
Die nationale Gesundheitsbehörde gibt grünes Licht, Experten warnen vor einer voreiligen Verabreichung einer Vakzine. Die US-Regierung hat die Bundesstaaten aufgefordert, für die Verteilung eines möglichen Corona-Impfstoffes ab dem 1. November bereit zu sein. Der Chef der Gesundheitsbehörde CDC (Centers for Disease Control and Prevention), Robert Redfield, appellierte in einem am Mittwoch bekannt gewordenen Brief an die Gouverneure, die Fertigstellung von Verteilzentren bis zu diesem Datum sicherzustellen. Verteilzentren rüsten sich Zum 1. November müssten die Zentren "vollständig einsatzfähig" sein, heißt es in dem Schreiben von Ende August. Dazu müssten womöglich Vorgaben für Geschäfts- und Baugenehmigungen für das Unternehmen McKesson, das einen künftigen Impfstoff im Land verteilen soll, gelockert werden. Der Brief zeigt den Willen der Regierung von Präsident Donald Trump, noch vor der Präsidentschaftswahl am 3. November einen Impfstoff zu genehmigen. Trump hat wiederholt die Hoffnung geäußert, dass ein Impfstoff zur Eindämmung der Pandemie bald zur Verfügung stehen könnte.

 関連キーワード  (小売_医薬品 米国株 MCK マケッソン MCK )

 twitter  (公式ツイッターやCEOツイッターなど)